What is UroGen Pharma's change in inventories?

UroGen Pharma (URGN) reported change in inventories of $4.46M in Q1 2026.

How has UroGen Pharma's change in inventories changed year-over-year?

UroGen Pharma's change in inventories increased by 372.3% year-over-year, from -$1.64M to $4.46M.

What is the long-term trend for UroGen Pharma's change in inventories?

Over 2 years (2021 to 2025), UroGen Pharma's change in inventories has grown at a 58.9% compound annual growth rate (CAGR), from $2.87M to $7.24M.

What does change in inventories mean?

Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.

UroGen Pharma URGN Change in Inventories

Change in Inventories at other companies

Bristol-Myers SquibbBMY

-$14M-108%

PfizerPFE

-$140.25M-166%

Johnson & JohnsonJNJ

$431M+195%

Merck & Co.MRK

$295M+41.3%

ImmunityBio, Inc.IBRX

$4.99M+2,798%

CG OncologyCGON

-$72K—

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's change in inventories?: UroGen Pharma (URGN) reported change in inventories of $4.46M in Q1 2026.
How has UroGen Pharma's change in inventories changed year-over-year?: UroGen Pharma's change in inventories increased by 372.3% year-over-year, from -$1.64M to $4.46M.
What is the long-term trend for UroGen Pharma's change in inventories?: Over 2 years (2021 to 2025), UroGen Pharma's change in inventories has grown at a 58.9% compound annual growth rate (CAGR), from $2.87M to $7.24M.
What does change in inventories mean?: Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.